V Popescu C Leasu D Stana C Alexandrescu A Dumitrescu
J Med Life
2015 Jan-Mar;8(1):103-5.
bevacizumab glaucoma trabeculectomy vascular endothelial growth factor
CC BY
https://pubmed.ncbi.nlm.nih.gov/25914750/
Angiogenesis Inhibitors / therapeutic use Bevacizumab / pharmacology Bevacizumab / therapeutic use Conjunctiva / drug effects Glaucoma / drug therapy
Angiogenesis Inhibitors / therapeutic use Bevacizumab / pharmacology Bevacizumab / therapeutic use Conjunctiva / drug effects Glaucoma / drug therapy Case Reports Research Support, Non-U.S. Gov't Aged Angiogenesis Inhibitors / pharmacology Conjunctiva / pathology Female Glaucoma / pathology Humans Neovascularization, Pathologic / drug therapy Angiogenesis Inhibitors Bevacizumab
PMC4397507
25914750
The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report
2015